These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 16463405)

  • 1. Drug evaluation and approval process in the European Union.
    San Miguel MT; Vargas E
    Arthritis Rheum; 2006 Feb; 55(1):12-4. PubMed ID: 16463405
    [No Abstract]   [Full Text] [Related]  

  • 2. [New drugs and European procedures of approval. The European Agency for the Evaluation of Medicinal Products' role].
    Ainsworth MA
    Ugeskr Laeger; 2003 Apr; 165(16):1648-9. PubMed ID: 12756819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EU directive on clinical trials penalizes small sponsors.
    Meldolesi A
    Nat Biotechnol; 2003 Aug; 21(8):838. PubMed ID: 12894186
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experiences of the drug approval processes in the European Union].
    Pasanen M; Toivonen M
    Duodecim; 2000; 116(24):2817-22. PubMed ID: 12077887
    [No Abstract]   [Full Text] [Related]  

  • 5. [The role of the Danish Medical Products Agency in clinical trials].
    Simonsen AC
    Ugeskr Laeger; 2003 Apr; 165(16):1653-6. PubMed ID: 12756821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug regulation in the European Union.
    Griffin JP
    Adverse Drug React Toxicol Rev; 2000 Aug; 19(3):179-206. PubMed ID: 11059359
    [No Abstract]   [Full Text] [Related]  

  • 7. When EMA and FDA decisions conflict: differences in patients or in regulation?
    Wolfe SM
    BMJ; 2013 Aug; 347():f5140. PubMed ID: 23970394
    [No Abstract]   [Full Text] [Related]  

  • 8. Fractured European market undermines biosimilar launches.
    Moran N
    Nat Biotechnol; 2008 Jan; 26(1):5-6. PubMed ID: 18183000
    [No Abstract]   [Full Text] [Related]  

  • 9. [Editorial Letter. Drug approval].
    Borvendég J
    Neuropsychopharmacol Hung; 2011 Jun; 13(2):54-5. PubMed ID: 21919287
    [No Abstract]   [Full Text] [Related]  

  • 10. [Marketing of pediatric drugs].
    Pabst JY
    Soins Pediatr Pueric; 2003; (210):18-9. PubMed ID: 12683130
    [No Abstract]   [Full Text] [Related]  

  • 11. [France in the European cooperation for the technological evaluation of health products].
    Meyer F
    Med Sci (Paris); 2018 May; 34 Hors série n°1():57-59. PubMed ID: 29911568
    [No Abstract]   [Full Text] [Related]  

  • 12. Registration of similar biological products--Singapore's approach.
    Poh J; Tam KT
    Biologicals; 2011 Sep; 39(5):343-5. PubMed ID: 21783381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The special treatment.
    Osborne R
    Nat Biotechnol; 2008 May; 26(5):487-9. PubMed ID: 18464770
    [No Abstract]   [Full Text] [Related]  

  • 14. Europe's opportunity to open up drug regulation.
    Garattini S; Bertele' V
    BMJ; 2010 Mar; 340():c1578. PubMed ID: 20354022
    [No Abstract]   [Full Text] [Related]  

  • 15. Report calls for major changes in drug-approval process, but will they be implemented?
    Robinson A
    CMAJ; 1993 Feb; 148(3):432-5. PubMed ID: 8439917
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteriation of clinical data packages using foreign data in new drug applications in Japan.
    Tanaka M; Nagata T
    Clin Pharmacol Ther; 2008 Sep; 84(3):340-6. PubMed ID: 17786162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs approval process gets speed treatment.
    Klarreich E
    Nature; 2001 Jul; 412(6845):364. PubMed ID: 11473269
    [No Abstract]   [Full Text] [Related]  

  • 18. [Does collaboration inside the European Union improve Finnish drug safety?].
    Palva E
    Duodecim; 2000; 116(24):2810-1. PubMed ID: 12077885
    [No Abstract]   [Full Text] [Related]  

  • 19. The European Medicines Agency's plans for sharing data from clinical trials.
    Groves T; Godlee F
    BMJ; 2013 May; 346():f2961. PubMed ID: 23657192
    [No Abstract]   [Full Text] [Related]  

  • 20. New drug approval times and clinical evidence in Japan.
    Ono S; Yoshioka C; Asaka O; Tamura K; Shibata T; Saito K
    Contemp Clin Trials; 2005 Dec; 26(6):660-72. PubMed ID: 16122988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.